- Home
- POLEW vs CRL Comparison
POLEW vs CRL Comparison
Compare POLEW & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLEW
- CRL
- Stock Information
- Founded
- POLEW N/A
- CRL 1947
- Country
- POLEW United States
- CRL United States
- Employees
- POLEW N/A
- CRL N/A
- Industry
- POLEW
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- POLEW
- CRL Health Care
- Exchange
- POLEW Nasdaq
- CRL Nasdaq
- Market Cap
- POLEW N/A
- CRL 9.8B
- IPO Year
- POLEW 2024
- CRL 2000
- Fundamental
- Price
- POLEW $0.15
- CRL $186.00
- Analyst Decision
- POLEW
- CRL Hold
- Analyst Count
- POLEW 0
- CRL 13
- Target Price
- POLEW N/A
- CRL $211.64
- AVG Volume (30 Days)
- POLEW N/A
- CRL 531.0K
- Earning Date
- POLEW N/A
- CRL 02-12-2025
- Dividend Yield
- POLEW N/A
- CRL N/A
- EPS Growth
- POLEW N/A
- CRL N/A
- EPS
- POLEW N/A
- CRL 8.00
- Revenue
- POLEW N/A
- CRL $4,060,916,000.00
- Revenue This Year
- POLEW N/A
- CRL N/A
- Revenue Next Year
- POLEW N/A
- CRL $1.18
- P/E Ratio
- POLEW N/A
- CRL $23.28
- Revenue Growth
- POLEW N/A
- CRL N/A
- 52 Week Low
- POLEW N/A
- CRL $176.48
- 52 Week High
- POLEW N/A
- CRL $275.00
- Technical
- Relative Strength Index (RSI)
- POLEW N/A
- CRL 42.30
- Support Level
- POLEW N/A
- CRL $180.21
- Resistance Level
- POLEW N/A
- CRL $188.04
- Average True Range (ATR)
- POLEW 0.00
- CRL 5.75
- MACD
- POLEW 0.00
- CRL -0.85
- Stochastic Oscillator
- POLEW 0.00
- CRL 24.30
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.